Genomics Market in US 2023-2027

Genomics Market In US 2023-2027
The genomics market in US is forecasted to grow by USD 5,284.67 mn during 2022-2027, accelerating at a CAGR of 10.45% during the forecast period. The report on the genomics market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by a reduction in the cost of genetic sequencing, increasing demand for creating and upgrading genome databases, and growing demand for personalized medicine.

Technavio's genomics market in US is segmented as below:

By ApplicationDiagnosticDrug discoveryOthersBy End-userHospitals and clinicsAcademic and research institutesPharmaceutical and biotechnology companiesOthersBy SolutionProductsServicesThis study identifies the growing adoption of single cell-based genomics analysis as one of the prime reasons driving the genomics market in US growth during the next few years. Also, advances in sequencing technologies and growing applications of genomics in oncology will lead to sizable demand in the market.

The report on the genomics market in US covers the following areas:Genomics market in US sizingGenomics market in US forecastGenomics market in US industry analysisThe robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genomics market in US vendors that include Agilent Technologies Inc., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Caris Life Sciences, CENTOGENE NV, Color Health Inc., Danaher Corp., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Invitae Corp., LetsGetChecked, Myriad Genetics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., PerkinElmer Inc., Personalis Inc., QIAGEN NV, Thermo Fisher Scientific Inc., and Twist Bioscience Corp.. Also, the genomics market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.